BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Giani T, Madera A, Cimaz R. Association of juvenile idiopathic arthritis and morphea: a case series. Clin Rheumatol 2020;39:1341-5. [PMID: 31838640 DOI: 10.1007/s10067-019-04850-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Li SC. Treatment of juvenile localized scleroderma: current recommendations, response factors, and potential alternative treatments. Curr Opin Rheumatol 2022;34:245-54. [PMID: 35880663 DOI: 10.1097/BOR.0000000000000886] [Reference Citation Analysis]
2 Lachance AH, Goldman N, Kassamali B, Vleugels RA. Immunologic underpinnings and treatment of morphea. Expert Review of Clinical Immunology. [DOI: 10.1080/1744666x.2022.2063841] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Muzaffer MA, Abdelgalil AA. Tocilizumab in management of refractory juvenile idiopathic arthritis, 10 years of experience at tertiary university hospital. Egypt Rheumatol Rehabil 2021;48. [DOI: 10.1186/s43166-021-00074-1] [Reference Citation Analysis]